Skip to main content
TipRanks
Go Ultimate75% OFF

SK bioscience Co.,Ltd. (302440) Ratios

1 Followers

SK bioscience Co.,Ltd. Ratios

KR:302440's free cash flow for Q3 2026 was ₩-14.85B. For the 2026 fiscal year, KR:302440's free cash flow was decreased by ₩-7.77B and operating cash flow was ₩-7.09B. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio3.825.0810.204.694.00
Quick Ratio3.244.409.604.203.70
Cash Ratio0.321.010.940.590.21
Solvency Ratio0.04-0.010.380.370.73
Operating Cash Flow Ratio0.31-0.410.22-0.331.17
Short-Term Operating Cash Flow Coverage27.31-18.400.00-1.509.00
Net Current Asset Valueâ‚© 327.84Bâ‚© 755.53Bâ‚© 1.23Tâ‚© 1.38Tâ‚© 1.33T
Leverage Ratios
Debt-to-Assets Ratio0.160.140.010.050.05
Debt-to-Equity Ratio0.260.220.010.070.07
Debt-to-Capital Ratio0.210.180.010.060.06
Long-Term Debt-to-Capital Ratio0.210.180.000.000.02
Financial Leverage Ratio1.651.581.091.231.32
Debt Service Coverage Ratio-2.330.2641.831.775.98
Interest Coverage Ratio-16.10-37.57-3.3846.74138.38
Debt to Market Cap0.120.100.000.010.01
Interest Debt Per Share6129.725135.93286.491509.431433.50
Net Debt to EBITDA-6.04-2.21-2.45-0.650.02
Profitability Margins
Gross Profit Margin9.13%11.58%38.38%52.46%61.39%
EBIT Margin-23.23%-31.93%2.36%31.57%51.08%
EBITDA Margin-9.26%-13.53%11.77%37.53%53.07%
Operating Profit Margin-23.23%-51.74%-1.28%25.18%51.05%
Pretax Profit Margin-13.18%-33.31%1.98%31.03%50.71%
Net Profit Margin-8.62%-20.14%6.04%26.81%38.23%
Continuous Operations Profit Margin-8.62%-18.73%6.04%26.81%38.23%
Net Income Per EBT65.42%60.47%304.59%86.40%75.38%
EBT Per EBIT56.74%64.37%-154.88%123.23%99.35%
Return on Assets (ROA)-1.90%-1.89%1.20%5.72%16.83%
Return on Equity (ROE)-3.14%-2.99%1.31%7.03%22.18%
Return on Capital Employed (ROCE)-5.75%-5.47%-0.28%6.53%28.74%
Return on Invested Capital (ROIC)-3.75%-3.06%-0.27%5.35%20.88%
Return on Tangible Assets-2.03%-1.98%1.22%5.77%16.97%
Earnings Yield-1.49%-1.38%0.40%2.17%2.06%
Efficiency Ratios
Receivables Turnover4.901.4241.4111.5419.30
Payables Turnover16.7713.2867.5619.645.62
Inventory Turnover3.131.122.821.162.66
Fixed Asset Turnover0.580.271.171.564.20
Asset Turnover0.220.090.200.210.44
Working Capital Turnover Ratio0.600.210.280.331.21
Cash Conversion Cycle169.41555.27132.70328.1191.39
Days of Sales Outstanding74.50257.028.8231.6318.91
Days of Inventory Outstanding116.68325.74129.29315.05137.41
Days of Payables Outstanding21.7627.495.4018.5864.93
Operating Cycle191.17582.76138.11346.69156.32
Cash Flow Ratios
Operating Cash Flow Per Share1310.72-1658.27382.65-1628.857014.30
Free Cash Flow Per Share-1030.39-3889.13-273.15-2625.906433.00
Dividend Paid and CapEx Coverage Ratio0.56-0.740.58-1.6312.07
Capital Expenditure Coverage Ratio0.56-0.740.58-1.6312.07
Operating Cash Flow Coverage Ratio0.22-0.331.43-1.105.05
Operating Cash Flow to Sales Ratio0.16-0.480.08-0.270.58
Free Cash Flow Yield-2.14%-7.72%-0.37%-3.57%2.86%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-67.11-71.98251.8946.0548.47
Price-to-Sales (P/S) Ratio5.7914.5415.2112.3518.53
Price-to-Book (P/B) Ratio2.112.163.303.2410.75
Price-to-Free Cash Flow (P/FCF) Ratio-46.78-12.96-268.35-27.9934.98
Price-to-Operating Cash Flow Ratio36.77-30.39191.56-45.1232.08
Price-to-Earnings Growth (PEG) Ratio-25.960.21-3.08-0.700.05
Enterprise Value Multiple-68.54-109.71126.8132.2434.93
Enterprise Value4.13T3.97T5.52T5.53T17.22T
EV to EBITDA-68.54-109.71126.8132.2434.93
EV to Sales6.3514.8414.9312.1018.54
EV to Free Cash Flow-51.30-13.23-263.26-27.4334.99
EV to Operating Cash Flow40.33-31.02187.93-44.2332.09
Tangible Book Value Per Share23571.9724583.9421923.6822466.3120709.16
Shareholders’ Equity Per Share22872.6323348.9922216.5122703.3020932.18
Tax and Other Ratios
Effective Tax Rate0.350.44-2.050.140.25
Revenue Per Share8328.773465.564817.975953.4812143.80
Net Income Per Share-718.26-697.93291.001596.184642.34
Tax Burden0.650.603.050.860.75
Interest Burden0.571.040.840.980.99
Research & Development to Revenue0.150.270.230.130.05
SG&A to Revenue0.070.150.070.060.02
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality-1.792.551.31-1.021.51

Currency in KRW